Open AccessRole of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial
Author(s) -
Sunita Chauhan,
Hanish Kodali,
Jawad Noor,
Karuna Balwant Ramteke,
Vidisha Gawai
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/20628.9449
Subject(s) - postprandial , metformin , medicine , nausea , lipid profile , placebo , vomiting , gastroenterology , adverse effect , analysis of variance , omega 3 fatty acid , blood lipids , fatty acid , insulin , cholesterol , chemistry , biochemistry , polyunsaturated fatty acid , alternative medicine , pathology , docosahexaenoic acid
Diabetic dyslipidaemia is characterised by hypertriglyceridaemia, low High Density Lipoprotein (HDL), postprandial lipimea, small and dense LDL particles is considered to be a major predisposing factor for various macrovascular complications. Omega-3 fatty acids are fish oil derivative introduced in the market for dyslipidaemia associated with increased triglyceride level.